Zoetis Inc
NYSE:ZTS

Watchlist Manager
Zoetis Inc Logo
Zoetis Inc
NYSE:ZTS
Watchlist
Price: 176.96 USD 0.14% Market Closed
Market Cap: 79.8B USD
Have any thoughts about
Zoetis Inc?
Write Note

Wall Street
Price Targets

ZTS Price Targets Summary
Zoetis Inc

Wall Street analysts forecast ZTS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZTS is 222.28 USD with a low forecast of 173.84 USD and a high forecast of 260.4 USD.

Lowest
Price Target
173.84 USD
2% Downside
Average
Price Target
222.28 USD
26% Upside
Highest
Price Target
260.4 USD
47% Upside

ZTS Last Price Targets
Zoetis Inc

The latest public price target was made on Aug 7, 2024 by Balaji Prasad from Barclays , who expects ZTS stock to rise by 37% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Balaji Prasad
Barclays
242 USD
Upside 37%
3 months ago
Aug 7, 2024
Zoetis price target raised to $242 from $230 at Barclays
TheFly
Jonathan Block
Stifel Nicolaus
200 USD
Upside 13%
3 months ago
Aug 5, 2024
Zoetis Inc. (ZTS) PT Raised to $200 at Stifel
StreetInsider
David Westenberg
Piper Sandler
195 USD
Upside 10%
7 months ago
Apr 16, 2024
Zoetis price target lowered to $195 from $220 at Piper Sandler
TheFly
Jonathan Block
Stifel Nicolaus
195 USD
Upside 10%
7 months ago
Apr 2, 2024
Zoetis Inc. (ZTS) PT Lowered to $195 at Stifel
StreetInsider
Balaji Prasad
Barclays
Price Target 242 USD
Upside/Downside 37%
View Source
Jonathan Block
Stifel Nicolaus
Price Target 200 USD
Upside/Downside 13%
View Source
David Westenberg
Piper Sandler
Price Target 195 USD
Upside/Downside 10%
View Source
Jonathan Block
Stifel Nicolaus
Price Target 195 USD
Upside/Downside 10%
View Source
Zoetis Inc Competitors:
Price Targets
4015
Jamjoom Pharmaceuticals Factory Company SJSC
12% Upside
300119
Tianjin Ringpu Bio-Technology Co Ltd
11% Upside
4519
Chugai Pharmaceutical Co Ltd
19% Upside
300558
Betta Pharmaceuticals Co Ltd
5% Upside
NKTR
Nektar Therapeutics
298% Upside
SECARE
Swedencare AB (publ)
33% Upside
TORNTPHARM
Torrent Pharmaceuticals Ltd
12% Upside

Revenue
Forecast

Revenue Estimate
Zoetis Inc

For the last 8 years the compound annual growth rate for Zoetis Inc's revenue is 8%. The projected CAGR for the next 3 years is 7%.

8%
Past Growth
7%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zoetis Inc

For the last 8 years the compound annual growth rate for Zoetis Inc's operating income is 14%. The projected CAGR for the next 3 years is 11%.

14%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Zoetis Inc

For the last 8 years the compound annual growth rate for Zoetis Inc's net income is 27%. The projected CAGR for the next 3 years is 11%.

27%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZTS's stock price target?
Price Target
222.28 USD

According to Wall Street analysts, the average 1-year price target for ZTS is 222.28 USD with a low forecast of 173.84 USD and a high forecast of 260.4 USD.

What is Zoetis Inc's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Zoetis Inc's revenue is 8%. The projected CAGR for the next 3 years is 7%.

What is Zoetis Inc's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Zoetis Inc's operating income is 14%. The projected CAGR for the next 3 years is 11%.

What is Zoetis Inc's Net Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Zoetis Inc's net income is 27%. The projected CAGR for the next 3 years is 11%.

Back to Top